Episode 5: Oncogenic Fusion detection and reporting in NSCLC and solid tumors: from clinic to lab

Data & AI Oncology & Hematology Pre-launch
Summary

Episode 5 of the 'Better Testing, Better Treatment' podcast series focuses on the practical considerations for oncogenic fusion detection and reporting. In this episode, you can expect to hear our guests discuss the factors that go into deciding to test for oncogenic fusions, using IHC as a screening tool and more!

We're happy to welcome our guests Dr. James Solomon, Assistant Professor of Pathology and Laboratory Medicine at Weill Cornell Medicine and Assistant Attending Physician at the New York Presbyterian Hospital and Dr. Ashish Saxena is an Assistant Professor of Medicine at Weill Cornell Medical College and Assistant Attending Physician at the New York-Presbyterian Hospital.

You can listen to previous episodes of the Better Testing, Better Treatment podcast now.

The Better Testing, Better Treatment Podcast
Listen to more episodes on Spotify and Apple Podcasts 
Find us on Podbean
Data & AI Oncology & Hematology Pre-launch
Share:

Sign up to our newsletter

Sign up to our bi-weekly newsletter covering the latest insights to optimize commercialization of diagnostic driven therapies to help empower your decisions.

READY TO DO COMMERCIALIZATION DIFFERENTLY?

Every patient journey contains opportunities to improve testing, engagement, and adoption. We can help you find them so more people get the right therapy sooner.